Moderna D
D
MRNA
26.280
USD
-0.82
(-3.03%)
مغلق
حجم التداول
378,541
الربح لكل سهم
-11
العائد الربحي
-
P/E
-3
حجم السوق
10,163,575,030
الأفكار والتحليلات أصول ذات صلة
الأخبار المقالات
العنوان: Moderna
القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.